Literature DB >> 25845033

The use of novel oral anticoagulants: the debate continues!

Massimo Franchini1, Claudio Velati2,3.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25845033      PMCID： PMC4385060          DOI： 10.2450/2015.0059-15

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  8 in total

Review 1.  New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Jeffrey I Weitz; John W Eikelboom; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  A new era for anticoagulants.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Eur J Intern Med       Date:  2009-06-30       Impact factor: 4.487

Review 4.  The treatment of venous thromboembolism with novel oral anticoagulants: warnings and limitations.

Authors:  Paolo Prandoni
Journal:  Blood Transfus       Date:  2015-04       Impact factor: 3.443

Review 5.  Which patients with venous thromboembolism should receive non-vitamin K antagonist oral anticoagulants? The majority.

Authors:  Nicoletta Riva; Walter Ageno
Journal:  Blood Transfus       Date:  2015-04       Impact factor: 3.443

Review 6.  Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis.

Authors:  M Franchini; C Mengoli; M Cruciani; C Bonfanti; P M Mannucci
Journal:  J Thromb Haemost       Date:  2014-07-24       Impact factor: 5.824

Review 7.  Venous thromboembolism in 2013: the advent of the novel oral anticoagulants.

Authors:  Paolo Prandoni
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

8.  European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation.

Authors:  Hein Heidbuchel; Peter Verhamme; Marco Alings; Matthias Antz; Werner Hacke; Jonas Oldgren; Peter Sinnaeve; A John Camm; Paulus Kirchhof
Journal:  Europace       Date:  2013-05       Impact factor: 5.214
  8 in total
  3 in total

Review 1.  How we treat bleeding associated with direct oral anticoagulants.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giancarlo M Liumbruno; Massimo Franchini
Journal:  Blood Transfus       Date:  2016-01-19       Impact factor: 3.443

Review 2.  Direct oral anticoagulants for extended treatment of venous thromboembolism: insights from the EINSTEIN CHOICE study.

Authors:  Davide Imberti; Fulvio Pomero; Daniela Mastroiacovo
Journal:  Blood Transfus       Date:  2019-04-30       Impact factor: 3.443

Review 3.  The evolution of anticoagulant therapy.

Authors:  Massimo Franchini; Giancarlo M Liumbruno; Carlo Bonfanti; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2015-12-16       Impact factor: 3.443
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.